- Report
- January 2026
- 135 Pages
Global
From €5282EUR$5,950USD£4,518GBP
- Report
- November 2025
- 120 Pages
Global
From €5282EUR$5,950USD£4,518GBP
- Report
- November 2025
- 150 Pages
Global
From €5282EUR$5,950USD£4,518GBP
- Report
- November 2025
- 120 Pages
Global
From €5282EUR$5,950USD£4,518GBP
- Report
- October 2025
- 180 Pages
Global
From €5282EUR$5,950USD£4,518GBP
- Report
- October 2025
- 120 Pages
Global
From €5282EUR$5,950USD£4,518GBP
- Report
- April 2026
- 138 Pages
Global
From €2662EUR$2,999USD£2,277GBP
€3550EUR$3,999USD£3,037GBP
- Report
- June 2026
- 142 Pages
Global
From €2662EUR$2,999USD£2,277GBP
€3550EUR$3,999USD£3,037GBP
- Report
- May 2026
- 147 Pages
Global
From €2662EUR$2,999USD£2,277GBP
€3550EUR$3,999USD£3,037GBP
- Report
- April 2026
- 149 Pages
Global
From €2662EUR$2,999USD£2,277GBP
€3550EUR$3,999USD£3,037GBP
- Report
- April 2026
- 143 Pages
Global
From €2662EUR$2,999USD£2,277GBP
€3550EUR$3,999USD£3,037GBP
- Report
- April 2026
- 140 Pages
Global
From €2662EUR$2,999USD£2,277GBP
€3550EUR$3,999USD£3,037GBP
- Report
- March 2026
- 145 Pages
Global
From €2662EUR$2,999USD£2,277GBP
€3550EUR$3,999USD£3,037GBP
- Report
- February 2026
- 143 Pages
Global
From €2662EUR$2,999USD£2,277GBP
€3550EUR$3,999USD£3,037GBP
- Report
- August 2026
- 380 Pages
Global
From €5193EUR$5,850USD£4,442GBP
- Report
- August 2026
- 200 Pages
Global
From €5193EUR$5,850USD£4,442GBP
- Report
- August 2026
- 184 Pages
Global
From €3147EUR$3,545USD£2,692GBP
€3497EUR$3,939USD£2,991GBP
- Report
- August 2026
- 182 Pages
Global
From €3147EUR$3,545USD£2,692GBP
€3497EUR$3,939USD£2,991GBP
- Report
- August 2026
- 184 Pages
Global
From €3147EUR$3,545USD£2,692GBP
€3497EUR$3,939USD£2,991GBP
- Report
- August 2026
- 187 Pages
Global
From €3147EUR$3,545USD£2,692GBP
€3497EUR$3,939USD£2,991GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more